Position in KURA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$6,691,535
New position
Shares Held
609,985
first reported quarter
Ownership
0.686%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#30
of 220 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026ROYCE & ASSOCIATES LP holds $280,034,602 across 30 Biotechnology names. KURA ranks #14 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
789,745 | $55,795,484 | |
| 2 | INVA |
Innoviva, Inc.
|
1,172,690 | $26,631,789 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
91,041 | $22,284,105 | |
| 4 | CRMD |
CorMedix Inc.
|
2,176,362 | $17,084,441 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
218,487 | $16,272,911 | |
| 6 | ALMS |
Alumis Inc.
|
525,303 | $14,782,026 | |
| 7 | HRMY |
Harmony Biosciences Holdings, Inc.
|
362,464 | $13,197,314 | |
| 8 | ZVRA |
Zevra Therapeutics, Inc.
|
882,658 | $12,657,315 |
All Filings in KURA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,691,535 | 609,985 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||